Jaguar Health's biggest risks in the FY2025 10-K
- Series O Preferred Stock dividend and conversion terms dominate the risk section.
- Potential conversion into common stock could dilute investors and pressure Jaguar Health’s share price.
- Dividend record-date and warrant-transfer rules may limit investor liquidity and create entitlement disputes.
The risks most specific to Jaguar Health
- Risks Related to the Preferred Stock Dividend
The Series O Preferred Stock is not freely transferable and therefore provides limited liquidity to investors
Series O Preferred Stock cannot be freely transferred, limiting investors’ ability to sell or obtain liquidity.
- Risks Related to the Preferred Stock Dividend
The potential issuance of a large number of shares of common stock upon the conversion of our Series O Preferred Stock may have a negative effect on the trading price of our common stock as well as a significant dilutive effect
Conversion of Series O Preferred Stock into common shares could significantly dilute existing holders and pressure Jaguar Health’s trading price.
- Risks Related to the Preferred Stock Dividend
Our board of directors set March 2, 2026 as the Preferred Stock Dividend Record Date and March 4, 2026 as the dividend payment date (the “Dividend Payment Date”)
Investors buying common stock between the March 2, 2026 record date and March 4, 2026 payment date may not receive the dividend.
- Risks Related to the Preferred Stock Dividend
The potential for the issuance of such a substantial number of shares of common stock may depress the price of our common stock regardless of our business performance. We may find it more difficult to raise additional equity capital while the Series O Preferred Stock is outstanding
The large potential share issuance could depress the stock price, restrict equity fundraising, and exceed available authorized shares if the conversion price falls.
- Risks Related to the Preferred Stock Dividend
Holders of Eligible Warrants will not actually receive the Preferred Stock Dividend unless and until the exercise of the Eligible Warrants and will cease to be entitled to the Preferred Stock Dividend upon transfer of the Eligible Warrants
Eligible warrant holders receive the Preferred Stock Dividend only by exercising before transfer, and lose the entitlement when transferring warrants.
Risk factor headings as read
Headings as the filing states them, in filing order.
Risks Related to the Preferred Stock Dividend
- 01The Series O Preferred Stock is not freely transferable and therefore provides limited liquidity to investors
- 02The potential issuance of a large number of shares of common stock upon the conversion of our Series O Preferred Stock may have a negative effect on the trading price of our common stock as well as a significant dilutive effect
- 03Our board of directors set March 2, 2026 as the Preferred Stock Dividend Record Date and March 4, 2026 as the dividend payment date (the “Dividend Payment Date”)
- 04The potential for the issuance of such a substantial number of shares of common stock may depress the price of our common stock regardless of our business performance. We may find it more difficult to raise additional equity capital while the Series O Preferred Stock is outstanding
- 05Holders of Eligible Warrants will not actually receive the Preferred Stock Dividend unless and until the exercise of the Eligible Warrants and will cease to be entitled to the Preferred Stock Dividend upon transfer of the Eligible Warrants
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.